Colasanti B K, Trotter R R
Curr Eye Res. 1981;1(9):501-6. doi: 10.3109/02713688109069175.
Ocular tension of conscious cats and rabbits was measured after topical application of clorgyline, a selective inhibitor of type A monoamine oxidase, or deprenyl, a selective inhibitor of line (1,4 and 12%) showed a dose-related reduction of intraocular pressure, with maximal lowerings amounting to 6 to 7 mm Hg. Pretreatment of eyes with clorgyline, 1%, markedly potentiated the pressure lowering response to epinephrine, 0.1%, applied topically. Sympathetic denervation almost completely abolished the effect of clorgyline. In contrast, deprenyl (2 to 8%) did not lower intraocular pressure after topical application to cat or rabbit eyes. beta-Phenylethylamine (2 to 16%) a specific substrate for the B form of monoamine oxidase, likewise did not lower ocular tension when given either alone or after pretreatment with deprenyl. These findings suggest that the intraocular pressure lowering effect of monoamine oxidase inhibitors is due primarily to inhibition of the A form of the enzyme and is dependent on intact sympathetic innervation.
给清醒的猫和兔子局部应用A型单胺氧化酶的选择性抑制剂氯吉兰或B型单胺氧化酶的选择性抑制剂司来吉兰后,测量其眼压。氯吉兰(1%、4%和12%)呈剂量依赖性降低眼压,最大降幅达6至7毫米汞柱。用1%的氯吉兰预处理眼睛,可显著增强对局部应用的0.1%肾上腺素的降压反应。交感神经去支配几乎完全消除了氯吉兰的作用。相比之下,司来吉兰(2%至8%)局部应用于猫或兔子眼睛后并未降低眼压。β-苯乙胺(2%至16%)是B型单胺氧化酶的特异性底物,单独给药或用司来吉兰预处理后给药均未降低眼压。这些发现表明,单胺氧化酶抑制剂的降眼压作用主要是由于对该酶A型的抑制,且依赖于完整的交感神经支配。